BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$263.86M
↑ 365% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-99.66M
Historical baseline
PeriodValueYoY Change
TTM$263.86M+396.9%
2024$-88.88M+60.8%
2023$-226.54M+8.3%
2022$-247.12M-34.3%
2021$-184.06M-0.7%
2020$-182.81M-67.9%
2019$-108.90M-7.6%
2018$-101.25M-53.9%
2017$-65.78M-19.3%
2016$-55.14M-